Hormone Therapy Effects on CVD Risk Factors
NCT00006313 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-05-13
Summary
To conduct extended analysis of the Postmenopausal Estrogen/Progestins Intervention PEPI trial database to address questions related to cardiovascular disease risk factor response and the possible determinants of this response.
Conditions
- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Postmenopause
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Eligibility
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-06-30
- Completion
- 2000-06-30
More Related Trials
-
Stroke and MI in Users of Estrogen/Progestogen
NCT00005466 ·Status: COMPLETED
-
Estrogen, Cytokines and Heart Failure in Women
NCT00041431 ·Status: COMPLETED ·Phase: NA
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Myocardial Infarction and Non-contraceptive Estrogen Use
NCT00005185 ·Status: COMPLETED
-
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
NCT00565916 ·Status: TERMINATED ·Phase: NA
-
Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 ·Status: COMPLETED
-
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Endogenous Estrogen and Coronary Heart Disease in Women
NCT00005446 ·Status: COMPLETED
-
Estrogen Replacement and Atherosclerosis (ERA) in Older Women
NCT00000549 ·Status: COMPLETED ·Phase: PHASE3
-
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001752 ·Status: COMPLETED ·Phase: PHASE2
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
Estrogen Diastolic Heart Failure
NCT02693002 ·Status: TERMINATED ·Phase: PHASE4
-
Estrogen Deficiency on Cardiovascular Risk
NCT06369363 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Perimenopausal Estrogen Replacement Therapy Study
NCT01308814 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Hormonal Replacement Therapy and Small Artery Function
NCT00564031 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
NCT00668603 ·Status: COMPLETED ·Phase: NA
-
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT00079248 ·Status: UNKNOWN ·Phase: NA
-
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
NCT00123539 ·Status: TERMINATED ·Phase: NA
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency
NCT06866119 ·Status: NOT_YET_RECRUITING
-
A Longitudinal Study to Identify Mechanisms of Menopause on Cardiovascular Disease Risk
NCT05647876 ·Status: RECRUITING
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA